Validation of a web-based clinical tool for predicting the risk of bronchopulmonary dysplasia in extremely preterm infants: a retrospective cohort study - Summary - MDSpire

Assessment of an Online Clinical Tool for Estimating Bronchopulmonary Dysplasia Risk in Extremely Preterm Infants: A Retrospective Cohort Analysis

  • By

  • Alaa Abuzaid

  • Shadi Noaman Garrada

  • Hebah Salem Abdullah Alsaihati

  • Zainab Alali

  • Fatimah Arif Alabbad

  • Jemila James

  • July 20, 2026

Share

Objective:

To evaluate the predictive accuracy of the NICHD bronchopulmonary dysplasia (BPD) outcome estimator for predicting grade 2 and grade 3 BPD and the composite outcome of death or grade 2 to grade 3 BPD at 36 weeks postmenstrual age.

Approach:
  • Study Design: Single-centred retrospective cohort study involving neonates with birth weights of 501–1250 g and gestational ages of 23+0 to 28+6 weeks.
  • Outcome Measurement: Used C-statistic receiver operating characteristic area under the curve (AUC) to predict outcomes on postnatal days 1, 3, 7, 14, and 28.
Key Findings:
  • AUC values were 0.71 on postnatal day 7 and 0.76 on postnatal day 14.
  • Prediction accuracy for the composite outcome of death or grade 2–3 BPD at 36 weeks PMA was found to have limited clinical utility.
Interpretation:

The NICHD web-based Neonatal BPD Outcome Estimator (2022) has moderate accuracy in predicting grade 2–3 BPD and the composite outcome of death or grade 2–3 BPD.

Limitations:
  • The study was conducted in a single centre, limiting generalizability.
  • The predictive performance may vary across different populations and settings.
Conclusion:

The findings indicate the need for cautious interpretation of the estimator's predictions.

Original Source(s)

Related Content